Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Account Payables (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Change in Account Payables data on record, last reported at $295000.0 in Q1 2013.

  • For Q1 2013, Change in Account Payables rose 455.42% year-over-year to $295000.0; the TTM value through Mar 2013 reached -$10000.0, down 106.33%, while the annual FY2025 figure was $416000.0, 249.64% up from the prior year.
  • Change in Account Payables reached $295000.0 in Q1 2013 per SNOA's latest filing, up from -$277000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $295000.0 in Q1 2013 and bottomed at -$277000.0 in Q4 2012.
  • Average Change in Account Payables over 4 years is -$9833.3, with a median of -$93000.0 recorded in 2012.
  • Peak YoY movement for Change in Account Payables: plummeted 210.96% in 2011, then soared 455.42% in 2013.
  • A 4-year view of Change in Account Payables shows it stood at -$138000.0 in 2010, then soared by 308.7% to $288000.0 in 2011, then plummeted by 196.18% to -$277000.0 in 2012, then surged by 206.5% to $295000.0 in 2013.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were $295000.0 in Q1 2013, -$277000.0 in Q4 2012, and $75000.0 in Q3 2012.